Agios Pharma's total assets for Q2 2025 were $1.47B, a decrease of -5.42% from the previous quarter. AGIO total liabilities were $101.68M for the fiscal quarter, a 14.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.